BRCA1 and breast cancer: Future studies screening BRCA1/BRCA2 mutations in an unselected BC population prospectively should be conducted to further examine differences in clinicopathological characteristics in BRCA1/BRCA2-positive and BRCA1/BRCA2-negative patients in the general BC population.